Latest News & Updates
Breaking News
31 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Alembic Clears FDA on Fingolimod, Pressing Into MS Generics
Alembic wins FDA final approval for Fingolimod 0.5 mg capsules, a generic equivalent to Novartis's Gilenya, advancing Indian generics in MS therapy.
Pharma Now Editorial Team
Sun Pharma-Organon Deal Reshapes Biosimilars and Women's Health Scale
Sun Pharma's $11.75B all-cash Organon deal expands biosimilars and women's health scale, raising GMP harmonization demands across a combined global network.
Pharma Now Editorial Team
WHO Prequalification of Novartis Pediatric Antimalarial Raises Bar for Fixed-Dose Combo Manufacturing
Novartis antimalarial FDC clears WHO review, raising formulation and GMP benchmarks for pediatric fixed-dose combination suppliers.
Pharma Now Editorial Team
Roche's Amylin Push Forces CDMOs to Rethink Capacity Plans
Roche's amylin-class weight-loss pipeline, developed with Zealand Pharma, raises urgent capacity and formulation questions for CDMOs.
Pharma Now Editorial Team
